Dallas, TX 1/8/2008 6:49:00 AM
News / Finance

Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: EGPI Firecreek, Inc. (OTCBB: EFCR), Integrated Management Information, Inc. (OTCBB: INMG), Ethos Environmental, Inc., (OTCBB: ETEV), Avitar Inc. (OTCBB: AVTI), and Auriga Laborat ...

To sign up for our free research reports and newsletters, visit http://BeaconEquityResearch.com. For more information on our research programs, please contact: Jeff Bishop at editor@beaconequityresearch.com

 

EGPI Firecreek, Inc. (OTCBB: EFCR) Up 65.71% on Monday

 

Detailed quote: http://beaconequityresearch.com/EFCR

 

January 07, 2008 - EGPI/Firecreek, Inc. Announces $2.1 Million Financing for First Quarter Oil & Gas Development Plans

 

EGPI Firecreek, Inc. (OTCBB: EFCR) and its wholly-owned subsidiary, Firecreek Petroleum, Inc. are pleased to announce that it has completed the sale of its Debentures for $2.1 million dollars to initiate the commencement of its oil and gas development plans for the first quarter 2008.

 

The financing will aid in the anticipated restructuring of the Company's operations, proposed acquisitions and corresponding work programs for new and existing oil and gas programs.

 

As part of EGPI's restructuring plan, the Company has approved a provision that will allow for the election of up to 5 new members to the Board of Directors. These individuals will consist of industry and finance professionals, and will give the Company an increased breadth of knowledge and credibility in the Oil and Gas industry.

 

Additionally, as part of the negotiating for its recently completed financing, the Company has successfully completed a wrap up and closure on all equity line sales through its prior financing arrangements. This wrap up is crucial in the Company's commitment to bring value to the shareholders by providing better terms in its current financing commitments and by restructuring any prior funding commitments so as to not suffer any potential dilutive effects, in the form of creating stock into the market by drawing from an equity line. The Company is confident that the closing of the equity line will now give the Company and its stock the potential to trade in parity with the Company's current events and future news releases.

 

Dennis Alexander, the Company's Chairman and CEO, stated, "We are extremely excited about the future outlook for EGPI/Firecreek. A tremendous effort has taken place in an effort to initiate our plans for Fiscal 2008 and the Company's long term future. We are now aggressively taking steps in an effort to build on the Company's domestic growth for oil and gas revenues and cash flow." Mr. Alexander also stated, "We also look forward to introducing the addition of our new Board members and working side by side with capable individuals who will bring knowledge, capacity and competent assistance in the vision, development and implementation of the Company's current and future business plans."

 

EGPI Firecreek, Inc. continues review for potential leases, interests and opportunities which are located throughout the U.S. and its surrounding regions. The Company is working on various financial opportunities for the funding of potential project acquisitions and the respective capital expenditure requirements for each.

 

Integrated Management Information, Inc. (OTCBB: INMG) Up 60.00% on Monday

 

Detailed quote: http://beaconequityresearch.com/INMG

 

January 07, 2008 - IMI Global Announces Stock Buyback Plan

 

Integrated Management Information, Inc. (IMI Global) (OTCBB: INMG), a leading provider of verification and Internet solutions for the agricultural/livestock industry, today announced that the Company intends to buy back up to one million shares of its common stock from the open market over the first six months of 2008.

 

John Saunders, president and CEO, said, "Management and the board of directors believe our shares represent an excellent value at current trading levels. Our intention is to make open market purchases from time to time at prices we believe to be advantageous to the Company and our shareholders. IMI Global has demonstrated solid, steady growth as a public company and foresees continued growth and progress in 2008 as we roll out new products and services and continue to expand our core offerings. We continue to be a leader and an aggressive innovator in an exciting growth industry. For a variety of reasons our share price has not reflected our revenue growth and improving bottom line, and this has created an opportunity for the Company to buy stock at very attractive levels."

 

Ethos Environmental, Inc., (OTCBB: ETEV) Up 50.00% on Monday

 

Detailed quote: http://beaconequityresearch.com/ETEV

 

January 07, 2008 - Ethos Bunker Fuel Conditioner Radically Reduces Carbon Monoxide in PetroEcuador Testing

 

Ethos Environmental, Inc., (OTC Bulletin Board: ETEV) is pleased to announce that recent testing performed at PetroEcuador's Esmeraldas refinery has resulted in a more than 50 percent reduction in carbon monoxide emissions with the use of Ethos Environmental's Bunker Fuel Conditioner.

 

Testing was conducted and monitored by the Center for Technical and Technological Environmental Services, an independent testing agency. The analysis of the testing data complied with approved international standards.

 

The testing protocol consisted of the addition of Ethos Bunker Fuel Conditioner to the heavy fuel oil powering PetroEcuador's electrical generation plant at Esmeraldas. Lab reports concluded that Ethos Bunker Fuel Conditioner reduced carbon monoxide emissions from the power generation process by more than 50 percent; reductions in other toxic emissions, including a 6.94% reduction in nitros oxide (NOx), also occurred. Furthermore, use of the Ethos Bunker Fuel Conditioner improved the plant's fuel efficiency, requiring less fuel to generate the normal amount of energy.

 

Ethos CEO Enrique de Vilmorin, expressing pleasure with the PetroEcuador test results, stated, "[w]e're all very impressed with the results from the Esmeraldas protocol testing. I'll be returning to Ecuador in February - to complete some 2007 business, and also to sign supply contracts covering 2008 and 2009."

 

During 2007, Ethos sales to PetroEcuador and Petro-Industrial exceeded $9 million. Ethos anticipates continued usage of its products by PetroEcuador and Petro-Industrial during the immediate future and beyond.

 

PetroEcuador, the state-run oil company of Ecuador, has managed the exploration, commercialization and transportation of Ecuador's petroleum resources for more than 25 years. Each month Petro-Industrial - the power generating division of PetroEcuador - consumes 16,000,000 gallons of Heavy Fuel Oil No. 6, with annual revenues exceeding $6 billion.

 

By significantly reducing carbon monoxide emissions, Ethos Bunker Fuel Conditioner provides a valuable pro-environment solution for industries dependent on heavy fuel oil. When added in proper concentration, the components of Ethos Bunker Fuel Conditioner improve fuel stability and also increase engine performance by cleaning and maintaining the entire fuel system.

 

Like the Esmeraldas power generation plant, ships burning heavy fuel oil can also benefit from the use of Ethos Bunker Fuel Conditioner. The international marine shipping fleet is a major contributor to the world's greenhouse gas emissions, as recently reported in the Wall Street Journal (Danger at Sea: Ships Draw Fire for Rising Role in Air Pollution, Nov 27, 2007). With the use of Ethos Bunker Fuel Conditioner, the potential exists for significantly reducing these emissions.

 

Avitar Inc. (OTCBB: AVTI) Up 46.67% on Monday

 

Detailed quote: http://beaconequityresearch.com/AVTI

 

January 07, 2008 - Avitar's Technology to be Used by Egyptian Government

 

Avitar Inc. ("AVTI") (OTCBB:AVTI), manufacturers of nationally branded oral fluid testing diagnostic devices and customized polyurethane applications used in wound dressings, announced today that the Company's ORALscreen rapid test for drugs-of-abuse and electronic reader has been approved by the Egyptian Government to be initially deployed by the Ministry of Tourism. Avitar's random on-site drug screening technology will be used to test all tour bus drivers, travel agents, and related personnel.

 

Peter Phildius, Avitar's Chairman and CEO said, "Egypt represents a significant business opportunity for Avitar. While we have previously focused our attention on the $1.5B existing market in the United States, we also must recognize the demand for our products world-wide. Egypt's population of 75 million is growing twice as fast as the US. The ORALscreen program is important to the Egyptian government's expanding efforts to address substance abuse in its society. Avitar will seize upon this opportunity to increase its reach in overseas markets, which currently represent approximately 10% of sales revenue."

 

Avitar's positioning as a consultative drug-free workplace technology and services provider, plays a central role in the model for convergence and integration efforts of its Egyptian business partners, the Ministry of Health, the Ministry of Tourism and the Ministry of the Interior.

 

Auriga Laboratories, Inc. (OTCBB: ARGA) Up 33.33% on Monday

 

Detailed quote: http://beaconequityresearch.com/ARGA

 

January 08, 2008 - Auriga Laboratories Signs Co-Promotion Agreement With MiddleBrook Pharmaceuticals for Keflex(R) 750 mg

 

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., pursuant to which Auriga will co-promote Keflex® 750 mg capsules (cephalexin capsules, USP), to Primary Care Specialists in the U.S.

 

Cephalexin, the generic form of Keflex, is the third most prescribed outpatient antibiotic in the U.S., with approximately 25 million prescriptions written annually. Cephalexin is the number-one most prescribed oral cephalosporin antibiotic and is also the number-one recommended oral antibiotic therapy for uncomplicated skin and skin structure infections.

 

The co-promotion will begin during the 1st Quarter of 2008. "This agreement solidifies Auriga's commitment to enhance our product portfolio. Currently, over 50% of cephalexin prescriptions are written by Primary Care Specialists which makes Keflex® 750 mg a highly synergistic addition to Auriga's current primary care promotional efforts," said Philip S. Pesin, CEO of Auriga.

 

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN THIS DOCUMENT. ALL INFORMATION PROVIDED HERE IS MERELY INFORMATIONAL AND IS NOT INTENDED TO BE A RECOMMENDATION TO BUY OR SELL ANY SECURITY. YOU SHOULD CONSULT A LICENSED INVESTMENT PROFESSIONAL BEFORE MAKING ANY INVESTMENT DECISION. All material herein has been prepared by us based upon information believed to be reliable. The information contained herein is not guaranteed by us to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not always approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. We are not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed or mentioned herein. Beacon Equity Research has not been compensated by any of the companies covered in this release. It is the policy of Beacon Research and its affiliates to sell any stock received for services, which may cause the stock price to become depressed. Our affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. We may sell shares for less than the target price given in this opinion, or at any time following the issuance of this announcement. We will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Beacon Research and its owners undertake no obligation to update such statements.